These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38692443)

  • 1. Unravelling the essential elements for recombinant adeno-associated virus (rAAV) production in animal cell-based platforms.
    Catalán-Tatjer D; Tzimou K; Nielsen LK; Lavado-García J
    Biotechnol Adv; 2024; 73():108370. PubMed ID: 38692443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular pathways of recombinant adeno-associated virus production for gene therapy.
    Sha S; Maloney AJ; Katsikis G; Nguyen TNT; Neufeld C; Wolfrum J; Barone PW; Springs SL; Manalis SR; Sinskey AJ; Braatz RD
    Biotechnol Adv; 2021; 49():107764. PubMed ID: 33957276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical challenges and advances in recombinant adeno-associated virus (rAAV) biomanufacturing.
    Fu Q; Polanco A; Lee YS; Yoon S
    Biotechnol Bioeng; 2023 Sep; 120(9):2601-2621. PubMed ID: 37126355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular design for recombinant adeno-associated virus (rAAV) vector production.
    Aponte-Ubillus JJ; Barajas D; Peltier J; Bardliving C; Shamlou P; Gold D
    Appl Microbiol Biotechnol; 2018 Feb; 102(3):1045-1054. PubMed ID: 29204900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Popularizing Recombinant Baculovirus-derived OneBac System for Laboratory Production of all Recombinant Adeno-associated Virus Vector Serotypes.
    Wu Y; Han Z; Duan M; Jiang L; Tian T; Jin D; Wang Q; Xu F
    Curr Gene Ther; 2021; 21(2):167-176. PubMed ID: 33461466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus as a delivery vector for gene therapy of human diseases.
    Wang JH; Gessler DJ; Zhan W; Gallagher TL; Gao G
    Signal Transduct Target Ther; 2024 Apr; 9(1):78. PubMed ID: 38565561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward exascale production of recombinant adeno-associated virus for gene transfer applications.
    Cecchini S; Negrete A; Kotin RM
    Gene Ther; 2008 Jun; 15(11):823-30. PubMed ID: 18401433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and purification of recombinant adeno-associated vectors.
    Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
    Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-adeno-associated virus hybrid for large-scale recombinant adeno-associated virus production.
    Zhang H; Xie J; Xie Q; Wilson JM; Gao G
    Hum Gene Ther; 2009 Sep; 20(9):922-9. PubMed ID: 19618999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in upstream process development for production of recombinant adeno-associated virus.
    Ou J; Tang Y; Xu J; Tucci J; Borys MC; Khetan A
    Biotechnol Bioeng; 2024 Jan; 121(1):53-70. PubMed ID: 37691172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manufacturing Clinical Grade Recombinant Adeno-Associated Virus Using Invertebrate Cell Lines.
    Kotin RM; Snyder RO
    Hum Gene Ther; 2017 Apr; 28(4):350-360. PubMed ID: 28351174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays.
    Buck TM; Wijnholds J
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of an rAAV Producer Cell Line through Synthetic Biology.
    Lee Z; Lu M; Irfanullah E; Soukup M; Hu WS
    ACS Synth Biol; 2022 Oct; 11(10):3285-3295. PubMed ID: 36219557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors.
    Handa A; Muramatsu SI; Qiu J; Mizukami H; Brown KE
    J Gen Virol; 2000 Aug; 81(Pt 8):2077-2084. PubMed ID: 10900047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
    Hirsch ML; Wolf SJ; Samulski RJ
    Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus System.
    Adamson-Small L; Potter M; Byrne BJ; Clément N
    Hum Gene Ther Methods; 2017 Feb; 28(1):1-14. PubMed ID: 28117600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant AAV Production.
    Joshi PRH; Venereo-Sanchez A
    Methods Mol Biol; 2024; 2829():203-214. PubMed ID: 38951336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery.
    Wang Q; Dong B; Firrman J; Roberts S; Moore AR; Cao W; Diao Y; Kapranov P; Xu R; Xiao W
    Hum Gene Ther Methods; 2014 Aug; 25(4):261-8. PubMed ID: 25093498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.